#332: Regulatory Strategy and the Advantage of Diversity in MedTech

Global Medical Device Podcast · 17 Aug 2023 · 50m · Episode 332

What this episode covers

Nada Hanafi, SVP of Regulatory Strategy at Veranex and co-founder of Medtech Color, discusses the critical importance of diversity in medical device design and regulatory strategy. She highlights how historical biases in validation, such as pulse oximeters failing on darker skin tones due to testing on Caucasian men, led to dire health outcomes. Hanafi explains how the FDA has evolved to prioritize transparency, health equity, and user-centered design, urging companies to define clear intended use and indications for use early in the development process. She emphasizes that incorporating diverse patient perspectives and data into AI training and clinical trials is no longer optional but a regulatory requirement for safety and efficacy.

Other shows on the same ground, closest first.

  • Let's Combinate · 1h 16m

    012 - "Asking then Seeing" with Sara Waxberg Mcnew

    Sara Waxberg McNew, Chief Scientific Officer at Design Science, explains the human factors process for medical devices, emphasizing the distinction between formative studies and summative validation. She details how to interpret ANSI/AAMI HE75 and IEC 62366-1 standards, manage risk for combination products, and handle regulatory submissions with the FDA. The discussion covers specific challenges like testing rare patient populations, using surrogates, and conducting threshold analyses for generics.

  • Let's Combinate · 32m

    107 - Distilling Decades of MedTech Data, Generative AI, and Doing Without Tribal Knowledge with Michelle Wu

    Michelle Wu, CEO and Founder of NyquistData, explains how her company uses generative AI to distill decades of MedTech data, removing the 'tribal knowledge' barrier for quality and regulatory professionals. She details the distinction between pre-trained models and fine-tuned algorithms, emphasizing that Nyquist’s data is validated and specific to FDA and global medical device regulations, unlike generic models like OpenAI. Wu discusses the challenge of changing organizational culture and overcoming skepticism in life sciences, highlighting features like the 'Device Explorer' and 'Data Writer' that democratize access to complex regulatory insights.

  • Being an Engineer · 45m

    S5E7 Matt Zachek | Medical Device Engineering Leaders 7

    Matt Zachek, Senior Director of R&D at Werfen, discusses his career path in medical device engineering, emphasizing the importance of technical foundations, grit, and managing ambiguity. He explains how balancing sustaining products with new R&D efforts requires a strategic portfolio approach, often following a 70-10-10-10 rule. Zachek highlights key industry trends, including the integration of AI tools like Google Gemini for research acceleration and the convergence of consumer electronics with regulated medical devices. He also stresses the value of early manufacturing involvement and in-situ empathy to navigate the complex regulatory landscape of hemostasis and acute care diagnostics.

  • Let's Combinate · 46m

    049 - "What Does the Data Say?" with Shannon Hoste

    Shannon Hoste, President of Agilis Consulting and former FDA reviewer, explains the regulatory framework for combination products, detailing the distinct roles of CDRH, CDER, and DMEPA in human factors reviews. She clarifies the critical distinction between design validation and human factors validation, emphasizing that the latter focuses specifically on safe and effective use rather than all user needs. Hoste also discusses the methodology for summative evaluations, including the rationale for the N=15 sample size per user group and strategies for recruiting representative participants to identify use errors.

  • Being an Engineer · 51m

    S1E13 A Holistic View on Product Development | Devon Campbell

    Devon Campbell, founder of Prodct LLC, discusses his advisory practice for early-stage biotech and medical device companies, drawing on his experience at Ventana Medical Systems, Quanterix, and Novartis. He explains how his background in machine shop operations and holistic product development—from design to field service—enabled his rapid rise to senior leadership roles. Campbell advocates for dual-career tracks in engineering, allowing brilliant technical contributors to become 'fellows' without becoming managers, and emphasizes the importance of integrating regulatory strategy (FDA, ISO 13485) from the earliest stages of product development to avoid costly rework.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.